Therapeutic agent for liver disease and piperazine derivatives

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/210, 167/223

A61K 31/55 (2006.01) A61K 31/495 (2006.01) C07D 295/21 (2006.01) C07D 317/60 (2006.01) C07H 15/26 (2006.01)

Patent

CA 1326451

THERAPEUTIC AGENT FOR LIVER DISEASE ABSTRACT OF DISCLOSURE A therapeutic agent for liver disease contain- ing as an active ingredient a piperazine derivative having the formula: Image wherein, A represents a phenyl, p-benzoquinonyl or cumarinyl group which may have at least one substituent selected from the group consisting of halogen, alkyl, fluoroalkyl, formyl, alkoxycarbonyl, acyl, hydroxy, alkoxy, acyloxy, glycosyloxy, amino, alkylamino, mercapto, alkylthio and nitro; B represents a single bond or a straight chain alkylene group containing 1-4 carbon atoms which may have at least one substituent selected from the group consisting of alkyl, aryl, aralkyl, hydroxy and oxo; R represents an atom or a group selected from the group consisting of hydrogen, alkali metal, alkaline earth metal, alkyl, cycloalkyl, aralkyl and aryl; and n is 2 or 3, or its pharmaceutically acceptable salt is diclosed.

589290

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Therapeutic agent for liver disease and piperazine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic agent for liver disease and piperazine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agent for liver disease and piperazine derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1281153

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.